MDS Pharma Services offers a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, we apply advanced scientific and technological expertise throughout the drug discovery and development process--from lead optimization, pre-IND research, early clinical research (bioequivalence, phases I-IIa) and bioanalysis through to global clinical development (phases IIb-IV), central lab and centralized cardiac services. For more information, visit our Web site at www.mdsps.com.

MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ), a global life sciences company.

Development and Regulatory Services

• Regulatory, scientific, clinical and program management expertise that adds value to drug and biopharmaceutical development programs
• Broad spectrum regulatory operations
• Expert and effective medical writing and publishing
• Proven regulatory expertise in INDs leading to timely approval
• Design and execution of first-in-human and special population studies
• Experience in developing biomarker strategy and execution

Pharmacology

• Biochemical, cellular, tissue, organ and other assays for profiling specificity and selectivity, and understanding the potential for adverse events
• Discovery ADME, metabolism resource and efficacy pharmacology
• Access to technical directors and demonstrated excellence in customer service
• Online catalog of 800+ assays at www.mdsps.com

Drug Safety Assessment

• Broad range of safety assessment programs, including a wide variety of administration routes
• Client-focused staff
• Comprehensive panel of toxicology and safety pharmacology services
• Commitment to on-time delivery of reports
• Recent expansion of our AAALAC-accredited facility

Early Clinical Research

• Phase I-IIa clinical trials
• More than 900 phase I beds
• Quality assurance
• Pharmacokinetics/pharmacodynamics analysis
• Statistical services
• Data management

Bioanalysis

• Preclinical and clinical program support
• Custom assay development
• Extensive list of nonproprietary assays
• Molecular and cell-based assays
• Biochemical markers
• Custom organic synthesis
• Radiolabeling
• Large molecule assays

Global Central Lab

• Full-service global central laboratory services
• Centralized cardiac safety assessment services for phase I-IV
• Method consistency and resource control at six company-owned and operated labs and affiliate labs
• Facilities in the United States, Canada, Germany, France, Singapore and China

Global Clinical Development

• Phase II-IV clinical trials
• Clinical project management and monitoring
• Worldwide clinical trial applications and submissions
• Feasibility research
• Data management (including EDC)
• Biostatistics
• Medical writing
• Global medical affairs and safety management
• Therapeutic expertise and consultancy
• Investigator and patient recruitment

For more information on our services, please contact us at the numbers listed below:

North America: 1-800-554-0502
Europe: +44-118-933-5300
Asia: +886-2-2892-3517

Contact Information

MDS Pharma Services

The Triad
2200 Renaissance Blvd.
Suite 400
King of Prussia, PA 19406-2755 USA
Phone: 610-239-7900
Fax: 610-239-7111
E-mail:

If you are interested in contacting this provider to receive further information about the services they offer, please fill out the form below to send a direct e-mail message.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:
	Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.